Roivant Sciences Ltd. (ROIV)
USD 9.0
(-4.86%)
USD 9.0
(-4.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 109.23 Million USD | 126.85% |
| 2023 | 109.23 Million USD | 3.96% |
| 2022 | 48.15 Million USD | 113.08% |
| 2021 | 46.32 Million USD | -67.34% |
| 2020 | 21.73 Million USD | 3774.16% |
| 2019 | 66.55 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 109.23 Million USD | 126.85% |
| 2024 Q1 | 17.41 Million USD | 108.64% |
| 2024 Q2 | 33.83 Million USD | -95.26% |
| 2024 Q3 | 33.47 Million USD | -1.07% |
| 2024 Q4 | 24.51 Million USD | -26.75% |
| 2023 Q1 | 2.59 Million USD | -70.41% |
| 2023 FY | 48.15 Million USD | 3.96% |
| 2023 Q4 | 23.2 Million USD | 72.29% |
| 2023 Q3 | 13.46 Million USD | 51.44% |
| 2023 Q2 | 8.89 Million USD | 242.92% |
| 2022 Q4 | 8.76 Million USD | -61.82% |
| 2022 FY | 46.32 Million USD | 113.08% |
| 2022 Q3 | 22.95 Million USD | 201.83% |
| 2022 Q2 | 7.6 Million USD | 8.77% |
| 2022 Q1 | 6.99 Million USD | -52.32% |
| 2021 Q1 | 1.39 Million USD | 100.7% |
| 2021 Q2 | 608 Thousand USD | -56.45% |
| 2021 Q4 | 14.66 Million USD | 189.54% |
| 2021 Q3 | 5.06 Million USD | 733.22% |
| 2021 FY | 21.73 Million USD | -67.34% |
| 2020 Q4 | -200.86 Million USD | 0.0% |
| 2020 FY | 66.55 Million USD | 3774.16% |
| 2019 FY | 1.71 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -187.272% |
| Alkermes plc | 1.37 Billion USD | 92.054% |
| Agenus Inc. | 139.61 Million USD | 21.76% |
| Aptorum Group Limited | -1.11 Million USD | 9899.603% |
| Ardelyx, Inc. | 106.66 Million USD | -2.413% |
| Dyadic International, Inc. | 922.95 Thousand USD | -11735.329% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -418.66% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 62576.05% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 917.759% |
| Novavax, Inc. | 639.93 Million USD | 82.93% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 333.214% |
| Pyxis Oncology, Inc. | -2 Million USD | 5561.75% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 21239.012% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -473.623% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 247305.124% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 20827.704% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 211.218% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -13520.324% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 133313.415% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 19.246% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1287.816% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 212.671% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 92.803% |
| AlloVir, Inc. | -398 Thousand USD | 27545.98% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 54.624% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -25662.972% |
| Bicycle Therapeutics plc | -129.52 Million USD | 184.338% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -90929.167% |
| ChromaDex Corporation | 50.78 Million USD | -115.114% |
| Chimerix, Inc. | 324 Thousand USD | -33614.506% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 450.475% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 240.77% |
| CRISPR Therapeutics AG | 240.95 Million USD | 54.666% |
| Precision BioSciences, Inc. | 40.47 Million USD | -169.903% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 211.279% |
| Fortress Biotech, Inc. | 57.85 Million USD | -88.815% |
| Fortress Biotech, Inc. | 57.85 Million USD | -88.815% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -558.955% |
| ImmuCell Corporation | 4.39 Million USD | -2384.712% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 202.932% |
| Immix Biopharma, Inc. | -5468.00 USD | 1997813.972% |
| Incyte Corporation | 3.44 Billion USD | 96.825% |
| Innoviva, Inc. | 261.06 Million USD | 58.158% |
| IO Biotech, Inc. | -756 Thousand USD | 14549.074% |
| Jaguar Health, Inc. | 7.72 Million USD | -1314.228% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 16551.054% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 8.783% |
| ContextLogic Inc. | 59 Million USD | -85.144% |
| MiMedx Group, Inc. | 266.84 Million USD | 59.064% |
| MEI Pharma, Inc. | 49.32 Million USD | -121.451% |
| NextCure, Inc. | -3.68 Million USD | 3065.119% |
| Onconetix, Inc. | -1.12 Million USD | 9791.128% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 477.089% |
| Opthea Limited | 21.72 Thousand USD | -502823.573% |
| Psyence Biomedical Ltd. | -240.00 USD | 45514683.333% |
| Vaxcyte, Inc. | -75 Million USD | 245.647% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 190650.536% |
| Precigen, Inc. | 106 Thousand USD | -102951.887% |
| Pharming Group N.V. | 220.1 Million USD | 50.371% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -21110.68% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -10726.065% |
| PureTech Health plc | -1.6 Million USD | 6914.41% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 0.489% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 160.215% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 341.004% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 596.816% |
| Acelyrin, Inc. | -115 Thousand USD | 95086.957% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1086907.283% |
| Summit Therapeutics Inc. | -2.05 Million USD | 5428.537% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 19230.473% |
| Senti Biosciences, Inc. | -2.68 Million USD | 4171.375% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -2596.495% |
| Elevation Oncology, Inc. | -39 Thousand USD | 280189.744% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2376.678% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2871.022% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -275.004% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -21923.185% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 198709.091% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -4.934% |
| Seer, Inc. | 7.02 Million USD | -1454.504% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2395.089% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -407.009% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 92288.436% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 76327.661% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -17836.782% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 9.329% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 65.175% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2184800.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -4143.784% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 215383.8% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -271.712% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 47184.052% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 22302.236% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1638.955% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 23118.892% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1050436.538% |
| Soligenix, Inc. | 97.31 Thousand USD | -112153.497% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1110.593% |
| Kura Oncology, Inc. | -849 Thousand USD | 12966.313% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 262.785% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 74409.524% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -10.295% |
| Autolus Therapeutics plc | -4.86 Million USD | 2344.401% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -163.942% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 65120.833% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -15.32% |
| GRI Bio, Inc. | 10.84 Million USD | -907.61% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -4200.614% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1357.454% |
| IGM Biosciences, Inc. | -211.66 Million USD | 151.609% |
| INmune Bio, Inc. | 155 Thousand USD | -70374.194% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -76.359% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 7351.919% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 16945.451% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 373246.82% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -27072.886% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 5572.695% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 34999.361% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -15.64% |
| Verastem, Inc. | -62 Thousand USD | 176285.484% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -4386.037% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 41952.49% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -3508.688% |
| Histogen Inc. | 3.76 Million USD | -2798.249% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -18858.518% |
| Surrozen, Inc. | -27.23 Million USD | 501.157% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2126.999% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 9166.048% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 525.917% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -444.759% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 5517019.192% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1700.649% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 162819.161% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 29.431% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -74821.125% |
| Apollomics, Inc. | 127 Thousand USD | -85911.811% |
| Amarin Corporation plc | 165.54 Million USD | 34.013% |
| Mesoblast Limited | -9.81 Million USD | 1212.939% |
| Turnstone Biologics Corp. | 16.5 Million USD | -561.79% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 198.865% |
| Synaptogenix, Inc. | -6347.00 USD | 1721149.315% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 214286.275% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 32.306% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 93.785% |
| Better Therapeutics, Inc. | -2.72 Million USD | 4102.748% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 197.391% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 67.69% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 957629.804% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1844.968% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 9958.755% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1392.689% |
| Insmed Incorporated | 239.63 Million USD | 54.416% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -2952.963% |
| OmniAb, Inc. | 14.66 Million USD | -644.767% |
| Alector, Inc. | -95.05 Million USD | 214.92% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 13.044% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 351.329% |
| Zai Lab Limited | 170.9 Million USD | 36.084% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -33.414% |
| Aura Biosciences, Inc. | -1.29 Million USD | 8535.135% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -83926.923% |
| Immunic, Inc. | -111 Thousand USD | 98509.91% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -589.006% |
| Veracyte, Inc. | 248.14 Million USD | 55.98% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.563% |
| FibroGen, Inc. | 128.9 Million USD | 15.259% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 19368007.801% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1036.282% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 96.786% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -27980.977% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 69.259% |
| TG Therapeutics, Inc. | 219.1 Million USD | 50.146% |
| Galecto, Inc. | -830 Thousand USD | 13260.843% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 7987.004% |
| Fortrea Holdings Inc. | 424 Million USD | 74.237% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 226.771% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 19365.432% |
| XBiotech Inc. | -1.74 Million USD | 6363.475% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 9958.755% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 335.061% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 244.617% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -48.815% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -550.092% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 71.922% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 320.023% |
| Vaxxinity, Inc. | -2.23 Million USD | 4989.66% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 66.569% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1064.646% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -346.751% |
| NexImmune, Inc. | -1.02 Million USD | 10757.364% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2022770.37% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1637.296% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.033% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 163559.38% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 3176.176% |
| Ainos, Inc. | -253.73 Thousand USD | 43151.16% |
| Pluri Inc. | 322 Thousand USD | -33823.913% |
| Prothena Corporation plc | -129.2 Million USD | 184.547% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -116.633% |
| Celularity Inc. | 6.75 Million USD | -1517.098% |
| Rallybio Corporation | -150 Thousand USD | 72923.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 435.005% |
| MeiraGTx Holdings plc | 287 Thousand USD | -37960.976% |
| Omeros Corporation | -69.77 Million USD | 256.544% |
| Humacyte, Inc. | -76.55 Million USD | 242.698% |
| Immunocore Holdings plc | 248.39 Million USD | 56.023% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 820.12% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -75.107% |
| Blueprint Medicines Corporation | 236.58 Million USD | 53.828% |
| CalciMedica, Inc. | -58 Thousand USD | 188436.207% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 7760.238% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -275.959% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 3940.893% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 453.912% |
| Pulmatrix, Inc. | -8.22 Million USD | 1428.893% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 9436.325% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 27477.193% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 127.391% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -3835.567% |
| Cytokinetics, Incorporated | -322.59 Million USD | 133.862% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -12570.73% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 32133.724% |
| Vor Biopharma Inc. | -3.49 Million USD | 3228.15% |
| Evogene Ltd. | 1.39 Million USD | -7708.077% |
| ProKidney Corp. | -3.16 Million USD | 3546.986% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 348.759% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1493.044% |
| CorMedix Inc. | -205.56 Thousand USD | 53239.685% |
| BioLineRx Ltd. | 1.1 Million USD | -9758.755% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 238.85% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 331115.152% |
| Atai Life Sciences N.V. | -5000.00 USD | 2184800.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 89740.486% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 113886.458% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 7964.291% |
| Sagimet Biosciences Inc. | 2 Million USD | -5361.75% |
| MediciNova, Inc. | 979.7 Thousand USD | -11049.785% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 229.55% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 115625.356% |
| GeoVax Labs, Inc. | -20.72 Million USD | 627.176% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 55.33% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2700.214% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 87.478% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1370.98% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 35337.097% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 910391.667% |
| Absci Corporation | -41.84 Million USD | 361.022% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2184800.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 243.028% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 4538.643% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 48.892% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 11708.395% |
| Allakos Inc. | -6.14 Million USD | 1878.782% |
| Imunon, Inc. | -720 Thousand USD | 15271.422% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 258.321% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 77.046% |
| BioAtla, Inc. | -103.73 Million USD | 205.306% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 957629.804% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 61467.978% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 144.986% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 35223.794% |
| XOMA Corporation | 3.86 Million USD | -2729.189% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 255.861% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -638.374% |
| aTyr Pharma, Inc. | -2.38 Million USD | 4674.33% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -776.685% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 376772.414% |
| Viridian Therapeutics, Inc. | -1 Million USD | 10936.806% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -840269130.769% |
| Akari Therapeutics, Plc | -4000.00 USD | 2730975.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 82.849% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -56001.958% |
| UroGen Pharma Ltd. | 73.35 Million USD | -48.919% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 509.212% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -940769.94% |
| Orgenesis Inc. | -5.72 Million USD | 2008.035% |
| Entera Bio Ltd. | -56 Thousand USD | 195162.5% |
| GH Research PLC | -315 Thousand USD | 34777.778% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 57896.296% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 20906.667% |
| Xencor, Inc. | -85.26 Million USD | 228.12% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 49532.746% |
| Replimune Group, Inc. | -2.65 Million USD | 4214.313% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 11010.015% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 38.578% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -56001.958% |
| Portage Biotech Inc. | -54 Thousand USD | 202387.037% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 115625.356% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 29074.801% |
| OncoCyte Corporation | 413 Thousand USD | -26349.153% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2430244.605% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 49205054.955% |
| Purple Biotech Ltd. | -196 Thousand USD | 55832.143% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1118.053% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1016.694% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1145.816% |
| HilleVax, Inc. | -2.15 Million USD | 5166.558% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 112713.402% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 728139.19% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 16452.545% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 475034.783% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1455371.404% |
| Savara Inc. | -44.26 Million USD | 346.792% |
| Curis, Inc. | 9.81 Million USD | -1013.393% |
| Daré Bioscience, Inc. | 2.76 Million USD | -3844.182% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 87636.462% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 6417.814% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 48010.088% |
| BeiGene, Ltd. | 2.07 Billion USD | 94.745% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 4006.971% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 127.332% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -92.695% |
| Erasca, Inc. | -3.73 Million USD | 3026.983% |
| bluebird bio, Inc. | -4.03 Million USD | 2810.546% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 387211.064% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 94.264% |
| DBV Technologies S.A. | 15.72 Million USD | -594.526% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 387211.064% |
| Moderna, Inc. | 2.15 Billion USD | 94.931% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 12038.251% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1264.414% |
| Molecular Templates, Inc. | 50.39 Million USD | -116.758% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 20479.664% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 18.352% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1855.625% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 377.648% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 198.297% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3144.454% |
| MacroGenics, Inc. | 50.52 Million USD | -116.191% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1891.325% |
| Prime Medicine, Inc. | -147.9 Million USD | 173.855% |
| Aditxt, Inc. | -111.66 Thousand USD | 97928.229% |
| Adagene Inc. | 18.11 Million USD | -503.125% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -22284.221% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 22.087% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 30.792% |
| SciSparc Ltd. | 2.19 Million USD | -4874.271% |
| Vericel Corporation | 135.57 Million USD | 19.429% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 436185.273% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 352675.689% |
| Generation Bio Co. | -73.91 Million USD | 247.793% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 25096.568% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -99.995% |
| Invivyd, Inc. | -2.02 Million USD | 5486.341% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 136.31% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 105704.323% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -13.352% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -11.138% |
| ADMA Biologics, Inc. | 88.21 Million USD | -23.824% |
| Clene Inc. | 533 Thousand USD | -20394.371% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -353.085% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 11514.316% |
| GeoVax Labs, Inc. | -20.72 Million USD | 627.176% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -5394.718% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 56315.134% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -119.325% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1640.257% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 13166.388% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -30.954% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -149307.758% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -105.476% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 163.073% |
| Trevena, Inc. | 1.45 Million USD | -7407.56% |
| Surrozen, Inc. | -27.23 Million USD | 501.157% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 31044.759% |
| Cingulate Inc. | -582.91 Thousand USD | 18839.342% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 352470.968% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 654.521% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1443098.679% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 12498.978% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 83.953% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 11156.174% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 193978.457% |
| Kronos Bio, Inc. | 1.37 Million USD | -7861.735% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 303.546% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 37509.247% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 22469.828% |
| ImmunityBio, Inc. | -17.89 Million USD | 710.593% |
| Korro Bio, Inc. | -3.63 Million USD | 3109.229% |
| Kineta, Inc. | 5.43 Million USD | -1910.583% |
| BioVie Inc. | -229.37 Thousand USD | 47722.473% |
| Codexis, Inc. | 57.33 Million USD | -90.524% |
| Celularity Inc. | 6.75 Million USD | -1517.098% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -2622.028% |
| Celcuity Inc. | -142.77 Thousand USD | 76610.1% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -215822.119% |
| Cibus, Inc. | 1.42 Million USD | -7581.786% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 29307.219% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 576.613% |
| IN8bio, Inc. | -2.5 Million USD | 4467.653% |
| Kodiak Sciences Inc. | -25.94 Million USD | 520.993% |
| Annexon, Inc. | -3.26 Million USD | 3443.587% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 5444.178% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 361.722% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -16967.969% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 85.969% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 36.842% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 5849.211% |
| Arcellx, Inc. | 108.27 Million USD | -0.883% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 437.468% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -37.916% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 616.429% |
| Moolec Science SA | -143.3 Thousand USD | 76325.533% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 358.129% |
| Geron Corporation | -123.5 Million USD | 188.447% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -3223.243% |
| Royalty Pharma plc | 1.79 Billion USD | 93.911% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 255.85% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3024324.806% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -47107.973% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 198.044% |
| Humacyte, Inc. | -76.55 Million USD | 242.698% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 11608.427% |
| 89bio, Inc. | -273 Thousand USD | 40112.821% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 8790.135% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 12981.486% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 88908.943% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -9661.841% |
| Notable Labs, Ltd. | 113 Thousand USD | -96568.142% |
| Liquidia Corporation | 14.6 Million USD | -648.185% |
| Mustang Bio, Inc. | -2.22 Million USD | 5009.438% |
| Immunovant, Inc. | -231 Thousand USD | 47387.879% |
| Quantum-Si incorporated | 488 Thousand USD | -22284.221% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 296.611% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 364216.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -5766.541% |
| Acasti Pharma Inc. | -11 Thousand USD | 993145.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 53485.105% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 16945.451% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 165.21% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -9527.792% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 28770.604% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 5678.907% |
| PepGen Inc. | -1.18 Million USD | 9325.929% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 86111.811% |
| United Therapeutics Corporation | 2.07 Billion USD | 94.723% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 577.071% |
| Solid Biosciences Inc. | -76.56 Million USD | 242.673% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 132372.986% |
| Immuneering Corporation | -764.13 Thousand USD | 14395.193% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -164748.183% |
| Belite Bio, Inc | -399 Thousand USD | 27477.193% |
| XOMA Corporation | 3.86 Million USD | -2729.189% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 645.194% |
| Bionomics Limited | -434.44 Thousand USD | 25243.342% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 10270.857% |
| uniQure N.V. | 2.21 Million USD | -4831.603% |
| Cassava Sciences, Inc. | -89.42 Million USD | 222.155% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 218.645% |
| Forte Biosciences, Inc. | -9000.00 USD | 1213822.222% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 13182.036% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 25096.568% |
| Altimmune, Inc. | -65.37 Million USD | 267.095% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 69.827% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 10270.857% |
| Compugen Ltd. | 31.45 Million USD | -247.274% |
| Peak Bio, Inc. | 367.76 Thousand USD | -29602.068% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -345.566% |
| Benitec Biopharma Inc. | 108 Thousand USD | -101043.519% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 140144.872% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 9180.216% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 6095.335% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 91894.118% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 9180.216% |
| Instil Bio, Inc. | -4.75 Million USD | 2396.783% |
| argenx SE | 1.1 Billion USD | 90.146% |
| Immunome, Inc. | -8.9 Million USD | 1326.395% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 5879.63% |
| Verona Pharma plc | -679.62 Thousand USD | 16172.858% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 62520.0% |
| Shattuck Labs, Inc. | -2.38 Million USD | 4680.084% |
| CervoMed Inc. | -1.29 Million USD | 8544.088% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 4638.222% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2386.686% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -4320.68% |
| Moolec Science SA | -143.3 Thousand USD | 76325.533% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 26871.316% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 4188.859% |
| AnaptysBio, Inc. | 14.78 Million USD | -639.023% |
| Design Therapeutics, Inc. | -537 Thousand USD | 20441.713% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 25681.967% |
| NeurAxis, Inc. | 2.15 Million USD | -4964.905% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -4990.168% |
| Lumos Pharma, Inc. | 2 Million USD | -5342.701% |
| Achilles Therapeutics plc | -4.73 Million USD | 2408.79% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 62520.0% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 103468.819% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -245.039% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -12570.73% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 10684.787% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 339.824% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -253934.884% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 13388.929% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 830279.359% |
| Palisade Bio, Inc. | 246 Thousand USD | -44304.472% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 331115.152% |
| Beam Therapeutics Inc. | -59.67 Million USD | 283.059% |
| Neurogene Inc. | -3.26 Million USD | 3448.712% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 21.603% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3058.694% |
| Sesen Bio, Inc. | 40 Million USD | -173.088% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 36879.461% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2812.54% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1241.909% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -675.817% |
| Athira Pharma, Inc. | -969 Thousand USD | 11372.962% |
| Vaccinex, Inc. | -16 Million USD | 782.548% |
| HCW Biologics Inc. | -574.82 Thousand USD | 19103.208% |
| XOMA Corporation | 3.86 Million USD | -2729.189% |
| Nektar Therapeutics | 53.47 Million USD | -104.262% |
| Arvinas, Inc. | 71.8 Million USD | -52.138% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 230.881% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 274.01% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 34023.913% |
| Rezolute, Inc. | -36 Thousand USD | 303530.556% |
| Clene Inc. | 533 Thousand USD | -20394.371% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 8507498.754% |
| BeyondSpring Inc. | 1.75 Million USD | -6138.435% |
| Synlogic, Inc. | -1.92 Million USD | 5777.495% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 295329.73% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1825.126% |
| Peak Bio, Inc. | 367.76 Thousand USD | -29602.068% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 676.043% |
| Krystal Biotech, Inc. | 47.6 Million USD | -129.461% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 22.578% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2073.831% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 4318.84% |
| MannKind Corporation | 136.19 Million USD | 19.793% |
| Ikena Oncology, Inc. | -50.49 Million USD | 316.341% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -0.387% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2591.106% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 43447.222% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2184800.0% |
| Legend Biotech Corporation | 140.92 Million USD | 22.489% |
| Mural Oncology plc | -2.56 Million USD | 4355.356% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 19924.864% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 109335.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -426.332% |
| REGENXBIO Inc. | 53.02 Million USD | -105.991% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2139.126% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 56882.326% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 6406.871% |
| Vaxart, Inc. | -60.76 Million USD | 279.772% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 41668.993% |
| Cellectis S.A. | 18 Thousand USD | -606761.111% |
| Longeveron Inc. | 221 Thousand USD | -49327.602% |
| Repare Therapeutics Inc. | -80.07 Million USD | 236.424% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 90.006% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 8541.654% |
| Revolution Medicines, Inc. | -399.66 Million USD | 127.332% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 312200.0% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -222828.571% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.731% |
| Denali Therapeutics Inc. | -93.34 Million USD | 217.023% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 436185.273% |
| Veru Inc. | 7.56 Million USD | -1343.775% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 72441.06% |
| Cingulate Inc. | -582.91 Thousand USD | 18839.342% |
| Passage Bio, Inc. | -3.72 Million USD | 3035.636% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 907066.124% |
| Exicure, Inc. | -1.42 Million USD | 7776.388% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 28620.888% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -3941.25% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 21406.871% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -60.343% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 73114.632% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 284.5% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -27837.34% |
| OmniAb, Inc. | 14.66 Million USD | -644.767% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -446.366% |
| Lipocine Inc. | -2.85 Million USD | 3931.707% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 6027.021% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2014.724% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 7351.919% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -45.036% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 168153.846% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -29.585% |
| Ocugen, Inc. | -33.53 Million USD | 425.715% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 3554.617% |
| Q32 Bio Inc. | 578 Thousand USD | -18798.789% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 41320.755% |
| Alumis Inc. Common Stock | -1.28 Million USD | 8607.399% |
| Equillium, Inc. | 35.95 Million USD | -203.785% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 6499.238% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -21717.372% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2642456.072% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 42275.676% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -25741.471% |
| Dominari Holdings Inc. | 2.03 Million USD | -5257.283% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 59638.02% |
| vTv Therapeutics Inc. | -13.59 Million USD | 903.494% |
| Bio-Techne Corporation | 773.07 Million USD | 85.87% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -530.723% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 76.294% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 9444.311% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 555.525% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -833.872% |
| Nkarta, Inc. | -5.86 Million USD | 1961.22% |
| BioCardia, Inc. | -7.24 Million USD | 1606.898% |
| Iterum Therapeutics plc | -1.75 Million USD | 6342.0% |